Log In
Print this Print this

D-QIV (GSK2321138A)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionIntramuscular quadrivalent influenza vaccine containing 2 strains of type A (H1N1 and H3N2) and 2 strains of type B (1 each from Yamagata and Victoria lineages)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentRegistration
Standard IndicationInfluenza virus
Indication DetailsVaccinate against seasonal influenza virus infection
Regulatory Designation U.S. - Undisclosed Review (Vaccinate against seasonal influenza virus infection);
EU - Standard Review (Vaccinate against seasonal influenza virus infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today